ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer
Clinical trial NCT03445000 · TERMINATED
Trial details
- NCT number
- NCT03445000
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-06
- Primary completion
- 2021-03-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.